Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.